Our people

Meet the team

Assaf Harel
CEO & Co-Founder

Assaf is an extremely experienced executive and technology enthusiastic, who has over 20 years in the software and IT industries; prior to founding Aneuscreen, Assaf held several senior managerial roles in deep technology companies, for the most part in the field of healthcare and digital health, among them are Medcon (Acquired by Mckesson), and MedCPU (Partnered with UPMC). He is also a serial entrepreneur, and as such was involved in Quiksee (Acquired by Google), and Checkmarx, a leading information security company, recently acquired for $1.15B by a private equity firm. Assaf is married to a high school literature teacher, and has 3 amazing, energetic boys.

Haim Ezer, MD
Chief Scientist Officer & Co-Founder

50 Years old Israeli neurosurgeon, with skull base and complex vascular subspecialties. Dr. Ezer studied medicine at Tel Aviv University, later to specialize in neurosurgery in the Tel Aviv medical center. While in the USA he experienced the huge impact of cerebral aneurysms rupture on patients and families, later to develop a method for preventing this rupture. Dr. Ezer is the author of "What is a thought" (Hebrew), a book explaining in common language how the brain works. Dr. Ezer developed novel surgical techniques and has several book chapters published as well as peer-reviewed articles. Dr. Ezer is married to an ICU nurse, and has 3 children.

Advisory Board Members

Aaron Cohen-Gadol, MD, PhD

Dr. Cohen-Gadol (Cohen) performed his undergraduate and medical school trainings in the University of California at San Diego and University of Southern California, respectively. He then completed his residency training at Mayo Clinic in Rochester, Minnesota.  He also completed fellowship training in two subspecialties: Epilepsy surgery (Yale University) and skull base/cerebrovascular surgery (University of Arkansas.) Dr. Cohen has a Masters Degree in Clinical Research from Mayo Graduate School and MBA from Kelley School of Business.

His areas of interest include surgical treatment of complex intracranial tumors and vascular lesions. He is a professor at Indiana University Department of Neurosurgery. He is the director of neurosurgical oncology and its fellowship, and co-director of the Signature Center for Brain and Neurological Tumors. He is the founder and president of The Neurosurgical Atlas (http://www.neurosurgicalatlas.com), a multimedia resource for neurosurgical techniques.

His clinical research interests include neurosurgical operative anatomy, innovative operative approaches to deep lesions, and intraoperative fluorescence/mass spectroscopy.  His basic science research is focused on novel drug therapies for glioblastoma.  He has published over 450 publications on the aforementioned topics.

He is one of the Directors-at-Large for the American Association of Neurological Surgeons (AANS) Board of Directors. He is also one of the Associate Editors of the Neurosurgical Focus.

Dr. Vitaliy L. Rayz, PhD

Dr. Rayz received his Ph.D. in Mechanical Engineering from the University of California, Berkeley in 2005, and his B.S. in Mechanical Engineering from the University of Wisconsin, Milwaukee in 1997. He currently serves as Assistant Professor of Biomedical Engineering at Purdue University.

Prior to joining Purdue University, Dr. Rayz served as an Assistant Professor in the Departments of Biomedical Engineering and Mechanical Engineering at University of Wisconsin-Milwaukee (2015-2017), and as an Adjunct Assistant Research Professor in Neurosurgery at the University of Arkansas for Medical Sciences. From 2008-2014 he was an Assistant Research Scientist in the Radiology Department at the University of California, San Francisco, and from 2005-2008 he was a Postdoctoral Fellow in Radiology Services at the VAMC in San Francisco.

Dr. Rayz’s research interests are in the field of biomechanical analysis of vascular disease initiation, progression, and treatment. In particular, his work involves modeling patient-specific hemodynamics in order to provide guidance to clinicians involved in the treatment of vascular disease.

LoriAnn V. Lowery-Biggers

LoriAnn is the CEO and co-founder of BellaVaughan, Inc., an award winning global diamond, design and manufacturing company with collections distributed worldwide through BlueNile, Inc., a Bain Capital Company.

LoriAnn has over 25 years of experience in the global finance and insurance industry, notably as President of Lloyd’s of London for North America. In executive roles at The Navigators Group, Inc (Nasdaq: NAVG), where she served in various capacities as President of Navigators Commercial Insurance Company, President of Field Operations and CMO. She held positions as the Managing Director and National Leader for Financial Products for Wells Fargo, Inc. and served as Vice-Chairman of Wells Fargo Management.

She is a board director and Chairperson of the Finance and Investment committee of Copper Point Mutual Insurance Holding Company, she is the Lead Independent Director of Brown & Riding Insurance, Inc., and she serves as a non-executive director and Deputy Chair of Nominating and Governance of Protective Insurance, Inc (NASDAQ: PTVCB). She serves on the board of BMS Holding Company, UK. She is on the board of advisors of The Legacy Fund. She serves on the board of the A21 Campaign, a 2017 Mother Teresa Harmony award recipient.

LoriAnn co-hosts The Leader’s Panel podcast with best selling author, Dr. Henry Cloud.

LoriAnn was chosen as a 2012 Reactions Magazine “12 Global Leaders to Watch” and 2015, 2014, 2013 and 2010 Reactions Magazine “Rising Star” award recipient. She is a 2008 Business Insurance Magazine “Woman to Watch” and a BI Magazine “Top 40 under 40 Executives”. She is a contributor for the Harvard curriculum, "How Star Women Succeed".